董事会认为在日本成立新子公司以进行战略业务发展，将增强集团在建立可持续商业模型方面的生态系 统，与我们的企业策略一致，专注于对知识产权和新商机的战略投资。 羚邦集团(02230)发布公告，一间新子公司"Medialink Japan株式会社"于2025年8月8日在日本正式成立， 这标志着我们在业务发展的"走向全球"策略上实现了一个重要的里程碑。鉴于集团作为亚洲领先的知识 产权管理公司，这家新子公司将通过探索以下机会来扩大集团的知识产权生态系统：(一)对日本知识产 权相关公司的併购或战略投资;(二)对日本知识产权的共同投资;以及(三)与日本知识产权拥有者和授权方 建立战略合作伙伴关系。新子公司将通过更多种类的非日本知识产权引入日本市场来增强我们的收入来 源。我们相信，此次扩张不仅将增强我们的竞争力，还将拓宽我们的销售网络，为集团的未来奠定坚实 的基础。 ...

智通财经APP讯，羚邦集团(02230)发布公告，一间新子公司"Medialink Japan 株式会社"于2025年8月8日 在日本正式成立，这标志着我们在业务发展的"走向全球"策略上实现了一个重要的里程碑。鉴于集团作 为亚洲领先的知识产权管理公司，这家新子公司将通过探索以下机会来扩大集团的知识产权生态系统： (一)对日本知识产权相关公司的併购或战略投资;(二)对日本知识产权的共同投资;以及(三)与日本知识产 权拥有者和授权方建立战略合作伙伴关系。新子公司将通过更多种类的非日本知识产权引入日本市场来 增强我们的收入来源。我们相信，此次扩张不仅将增强我们的竞争力，还将拓宽我们的销售网络，为集 团的未来奠定坚实的基础。 董事会认为在日本成立新子公司以进行战略业务发展，将增强集团在建立可持续商业模型方面的生态系 统，与我们的企业策略一致，专注于对知识产权和新商机的战略投资。 ...

格隆汇9月17日丨羚邦集团(02230.HK)宣布，一间新子公司"Medialink Japan 株式会社"于2025年8月8日 在日本正式成立，这标志着集团在业务发展的"走向全球"策略上实现了一个重要的里程碑。鉴于集团作 为亚洲领先的知识产权管理公司，这家新子公司将通过探索以下机会来扩大集团的知识产权生态系统： (一)对日本知识产权相关公司的并购或战略投资；(二)对日本知识产权的共同投资；以及(三)与日本知识 产权拥有者和授权方建立战略合作伙伴关系。新子公司将通过更多种类的非日本知识产权引入日本市场 来增强集团的收入来源。集团相信，此次扩张不仅将增强集团的竞争力，还将拓宽集团的销售网络，为 集团的未来奠定坚实的基础。 董事会认为在日本成立新子公司以进行战略业务发展，将增强集团在建立可持续商业模型方面的生态系 统，与集团的企业策略一致，专注于对知识产权和新商机的战略投资。 ...

香港交易及結算所有限公司及香港聯合交易所有限公司對本公告之內容概不負責，對其準確 性或完整性亦不發表任何聲明，並明確表示，概不對因本公告全部或任何部份內容而產生或 因倚賴該等內容而引致之任何損失承擔任何責任。 MEDIALINK GROUP LIMITED 本公司的董事會（「董事會」）欣然宣佈，一間新子公司「Medialink Japan 株式会社」 於2025年8月8日在日本正式成立，這標誌著我們在業務發展的「走向全球」策略 上實現了一個重要的里程碑。鍳於集團作為亞洲領先的知識產權管理公司， 這家新子公司將通過探索以下機會來擴大集團的知識產權生態系統：（一）對 日本知識產權相關公司的併購或戰略投資；（二）對日本知識產權的共同投資； 以及（三）與日本知識產權擁有者和授權方建立戰略合作伙伴關係。新子公司 將通過更多種類的非日本知識產權引入日本市場來增強我們的收入來源。我 們相信，此次擴張不僅將增強我們的競爭力，還將拓寬我們的銷售網絡，為集 團的未來奠定堅實的基礎。 羚邦集團有限公司 （於開曼群島註冊成立的有限公司） （股份代號：2230） 自願公告 在日本成立新子公司以進行戰略業務發展 本公告乃經羚邦集團有限公 ...

Financial Data and Key Metrics Changes - The company reported Q2 revenue of $621 million, bringing the first half total to $1.2 billion, with a net loss of $72 million, an improvement attributed to the absence of a non-cash impairment charge from the previous year [22][23] - Adjusted diluted EPS was $0.18, with operating cash flow of $116 million in the quarter [23][27] - Free cash flow for Q2 was $50 million, totaling $161 million for the first half of the year [27][28] - The mix of organic recurring revenue to total revenue for the first half improved to 88%, an increase of 800 basis points compared to the previous year [21] Business Line Data and Key Metrics Changes - The A and G business achieved 2% organic ACV and subscription revenue growth, with a 96% renewal rate [8][11] - The IP segment returned to organic growth in patent annuities, with recurring revenue rising by about 1.5% in the first half of 2025 [13][14] - Life Science and Healthcare segment saw a return to organic ACV growth, supported by a long-term multimillion-dollar agreement with a top pharmaceutical company [18][19] Market Data and Key Metrics Changes - The company noted a market-wide surge in AI innovation, which is expected to drive growth in the patent renewal business [14][15] - The U.S. dollar weakened against foreign currencies, providing a favorable foreign exchange translation impact on revenue [26][34] Company Strategy and Development Direction - The company is focused on a value creation plan (VCP) launched in 2024, emphasizing AI-led product innovation, improved sales execution, and operational efficiency [6][8] - A shift away from transactional sales towards subscription models is expected to enhance recurring revenue growth [10][11] - The company is undertaking a strategic review to assess alternatives across the business, with results expected to be communicated in February 2026 [19][20] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the renewal rates and the resilience of their products amid funding pressures in the U.S. market [54] - The company anticipates continued organic growth in the second half of the year, driven by improvements in the A and G and Life Sciences segments [36][37] - Management highlighted the importance of their products being mission-critical for universities, which supports renewal confidence [54] Other Important Information - The company has launched 10 AI-powered products since the launch of the VCP plan [9] - A new sales incentive plan has been initiated to refocus on subscription and recurring revenue, contributing to improved sales momentum [58][60] Q&A Session Summary Question: IP business rebound and AI opportunities - Management noted that the rebound in the IP annuity market is expected to benefit from increased patent filings related to AI, particularly in Asia and China [40][41][42] Question: Potential changes in U.S. patent filing fee structure - Management indicated that they are well-positioned to adapt to any changes in the IP ecosystem due to their long-standing presence and collaboration with patent offices and law firms [46][47][48] Question: University funding cuts and renewal outlook - Management reported strong renewal rates and emphasized the critical nature of their products for universities, which supports confidence in future renewals [53][54] Question: Sales momentum and subscription focus - Management expressed optimism about the sales momentum driven by the new sales incentive plan, focusing on subscription and recurring revenue [58][60] Question: Life Sciences and Healthcare market dynamics - Management highlighted stable R&D spending and improvements in the subscription business within Life Sciences and Healthcare, attributing this to investments in the Cortellis suite of products [64][66] Question: Delays in disposals - Management explained that one disposal is taking longer due to customer requests for more time to transition to alternative offerings [69][71]